Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density

PHASE2CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Osteoporosis
Interventions
DRUG

Placebo

oral, once daily

DRUG

DP001

oral, once daily

Trial Locations (9)

10993

Helen Hayes Hospital Clinical Research Center, West Haverstraw

11501

Winthrop University Hospital Bone Mineral Research Center, Mineola

16635

Altoona Center for Clinical Research, Duncansville

20817

Bethesda Health Research, Bethesda

46202

Indiana School of Medicine University Hospital, Indianapolis

53705

University of Wisconsin-Madison Osteoporosis Clinical Research, Madison

68131

Creighton University Bone Metabolism Unit, Omaha

87106

New Mexico Clinical Research and Osteoporosis Center, Albuquerque

91786

Boling Clinical Trials, Upland

Sponsors
All Listed Sponsors
lead

Deltanoid Pharmaceuticals

INDUSTRY